ArticleWorld journal of urology2026
Dorsal inlay lingual mucosa graft urethroplasty with artificial dermis donor repair for female urethral stricture.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveFemale urethral stricture (FUS) is a rare but challenging condition with no consensus on optimal management. Although the lingual mucosa graft (LMG) is an effective substitute tissue, concerns regarding donor site morbidity limit its use. This study evaluated the outcomes of dorsal inlay LMG urethroplasty for FUS and the effect of bilayer artificial dermis reconstruction on lingual donor site recovery.
methodsWe retrospectively reviewed 20 women who underwent dorsal inlay LMG urethroplasty between December 2019 and June 2024. The lingual donor defect was reconstructed using bilayer artificial dermis rather than primary closure. Outcomes included maximum urinary flow rate (Qmax), AUA Symptom Index (AUA-SI), and Quality of Life (QoL). Surgical success was defined as postoperative Qmax > 12 mL/s without additional intervention. Continence was assessed using the ICIQ-UI-SF. Donor site morbidity (pain, speech, diet) was evaluated using the Oral Mucositis Daily Questionnaire.
resultsMedian age was 52 years, median stricture length 2 cm, and median follow-up 16 months. Surgical success was achieved in 95% (19/20) of patients. At 12 months, voiding parameters improved significantly (p < 0.001): median Qmax increased from 6.5 to 20.5 mL/s, AUA-SI decreased from 25 to 4, and QoL improved from 5 to 1. No de novo stress or urge incontinence occurred. Donor site recovery was rapid, with pain resolving by day 14 and all patients regaining normal speech and diet without tongue deviation, contracture, or permanent numbness.
conclusionsDorsal inlay LMG urethroplasty is safe and effective for FUS in this cohort. Bilayer artificial dermis reconstruction of the donor site appears to facilitate rapid functional recovery and may mitigate concerns regarding lingual mucosa harvesting, though further comparative studies are required to confirm these benefits.
Indexed as
Identifiers
42771046What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.